| | 11096-26-7 Basic information More.. |
| Product Name: | Erythropoietin | | Synonyms: | Erythropoietin human,EPO;erythropoietin from human urine*approx 100 units;ANTI-ERYTHROPOIETIN(N-TERMINAL) antibody produced in rabbit;ANTI-ERYTHROPOIETIN(C-TERMINAL) antibody produced in rabbit;INN=Epoetin;ERYTHROPOIETIN RAT;Erythropoietin from rat;Erythropoietin from mouse | | CAS: | 11096-26-7 | | MF: | C22H22ClKN6O | | MW: | 461.00098 | | EINECS: | 234-317-2 | | Mol File: | 11096-26-7.mol |  |
Use
Recombinant erythropoietin (EPO) is currently indicated for use only in anemia associated with renal transplant or end-stage renal disease. Widened indications for use in other forms of anemia, accompanied by price reductions as a result of keen competition, have been projected for EPO in the future.
- EPO
-
- 2026-09-17
- CAS:11096-26-7
- Purity: 0.99
- EPO
-
- $5.00
- 2026-09-17
- CAS:11096-26-7
- Min. Order: 1Box
- Purity: 99.99%
- Supply Ability: 20000 boxes
- EPO
-
- $5.00
- 2026-09-17
- CAS:11096-26-7
- Min. Order: 1Box
- Purity: 99.9%
- Supply Ability: 10000000
|
|
11096-26-7
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|